0000899243-20-032868.txt : 20201207
0000899243-20-032868.hdr.sgml : 20201207
20201207163009
ACCESSION NUMBER: 0000899243-20-032868
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201207
DATE AS OF CHANGE: 20201207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ezekowitz Alan
CENTRAL INDEX KEY: 0001780209
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38978
FILM NUMBER: 201373047
MAIL ADDRESS:
STREET 1: C/O FULCRUM THERAPEUTICS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fulcrum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001680581
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474839948
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-651-8851
MAIL ADDRESS:
STREET 1: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-03
0
0001680581
Fulcrum Therapeutics, Inc.
FULC
0001780209
Ezekowitz Alan
C/O FULCRUM THERAPEUTICS, INC.
26 LANDSDOWNE STREET
CAMBRIDGE
CA
02139
1
0
0
0
Stock Option (right to buy)
11.82
2020-12-03
4
A
0
15000
0.00
A
2030-12-02
Common Stock
15000
15000
D
This option was granted on December 3, 2020 and is scheduled to vest with respect to all shares on November 2, 2021, subject to continued service.
/s/ Peter Thomson, as attorney-in-fact for Alan Ezekowitz
2020-12-07